Brief: Osteopore Ltd Collaborates With Singular Health Group
19/10/2021 01:54
Oct 19 (Reuters) - Osteopore Ltd OSX.AX :
* COLLABORATES WITH SINGULAR HEALTH TO VALIDATE
PATIENT-SPECIFIC
AI CRANIAL IMPLANT DESIGN TOOL
Source text for Eikon: ID:nASX2XNYHh
Further company coverage: OSX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Singular Health
See all newsBrief: Singular Health Group Receives US$3.0M From State Of Florida For Medical Imaging Data Repository
Brief: Singular Health Announces FDA 510(K) Clearance For 3Dicom MD Cloud
Australia's Singular Health hits two-month high on FDA clearance for medical imaging tech
Brief: Singular Health Signs USD$1.3M Contract With Provider Network Solutions
Brief: Singular Health Seeks Trading Halt